BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10662601)

  • 21. Regulation of IL-1-induced gingival collagenase gene expression by activator protein-1 (c-Fos/c-Jun).
    Hamid QA; Reddy PJ; Tewari M; Uematsu S; Tuncay OC; Tewari DS
    Cytokine; 2000 Nov; 12(11):1609-19. PubMed ID: 11052811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclic AMP stimulates a JunD/Fra-2 AP-1 complex and inhibits the proliferation of interleukin-6-dependent cell lines.
    Rezzonico R; Loubat A; Lallemand D; Pfarr CM; Far DF; Proudfoot A; Rossi B; Ponzio G
    Oncogene; 1995 Sep; 11(6):1069-78. PubMed ID: 7566966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decline in the expression of IL-2 after trauma and changes in the nuclear transcription factors NFAT and AP-1.
    Luo Y; Liang H; Hu C; Xu X; Wang Z
    Chin Med J (Engl); 2002 Sep; 115(9):1348-51. PubMed ID: 12411110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired AP-1 dimers and NFAT complex formation in immature thymocytes during in vivo glucocorticoid-induced apoptosis.
    Wisniewska M; Pyrzynska B; Kaminska B
    Cell Biol Int; 2004; 28(11):773-80. PubMed ID: 15563399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of multiple cis-acting elements mediating the induction of prostaglandin G/H synthase-2 by phorbol ester in murine osteoblastic cells.
    Okada Y; Voznesensky O; Herschman H; Harrison J; Pilbeam C
    J Cell Biochem; 2000 May; 78(2):197-209. PubMed ID: 10842315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
    Grau R; Iñiguez MA; Fresno M
    Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid, sequential activation of mitogen-activated protein kinases and transcription factors precedes proinflammatory cytokine mRNA expression in spleens of mice exposed to the trichothecene vomitoxin.
    Zhou HR; Islam Z; Pestka JJ
    Toxicol Sci; 2003 Mar; 72(1):130-42. PubMed ID: 12604842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of human thioltransferase (hTTase) gene by AP-1 transcription factor under oxidative stress.
    Krysan K; Lou MF
    Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1876-83. PubMed ID: 12036993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation.
    Yang HS; Knies JL; Stark C; Colburn NH
    Oncogene; 2003 Jun; 22(24):3712-20. PubMed ID: 12802278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vomitoxin-mediated IL-2, IL-4, and IL-5 superinduction in murine CD4+ T cells stimulated with phorbol ester calcium ionophore: relation to kinetics of proliferation.
    Ouyang YL; Azcona-Olivera JI; Murtha J; Pestka JJ
    Toxicol Appl Pharmacol; 1996 Jun; 138(2):324-34. PubMed ID: 8658534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitogen activated protein kinase-dependent activation of c-Jun and c-Fos is required for neuronal differentiation but not for growth and stress response in PC12 cells.
    Eriksson M; Taskinen M; Leppä S
    J Cell Physiol; 2007 Feb; 210(2):538-48. PubMed ID: 17111371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression and distribution of AP-1 transcription factors in the porcine ovary.
    Rusovici R; LaVoie HA
    Biol Reprod; 2003 Jul; 69(1):64-74. PubMed ID: 12606371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of repression of squamous differentiation marker, SPRR1B, in malignant bronchial epithelial cells: role of critical TRE-sites and its transacting factors.
    Patterson T; Vuong H; Liaw YS; Wu R; Kalvakolanu DV; Reddy SP
    Oncogene; 2001 Feb; 20(5):634-44. PubMed ID: 11313996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A peptide fragment of ependymin neurotrophic factor uses protein kinase C and the mitogen-activated protein kinase pathway to activate c-Jun N-terminal kinase and a functional AP-1 containing c-Jun and c-Fos proteins in mouse NB2a cells.
    Adams DS; Hasson B; Boyer-Boiteau A; El-Khishin A; Shashoua VE
    J Neurosci Res; 2003 May; 72(3):405-16. PubMed ID: 12692907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Transcription of c-fos gene and DNA binding activity of transcription factor AP-1 increase upon differentiation of mouse F9 teratocarcinoma cells].
    Chuĭkin IA; Lianguzova MS; Pospelov VA
    Tsitologiia; 2004; 46(12):1080-90. PubMed ID: 15747838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of the c-Jun N-terminal kinase pathway by 17beta-estradiol can preserve human islet functional mass from proinflammatory cytokine-induced destruction.
    Eckhoff DE; Smyth CA; Eckstein C; Bilbao G; Young CJ; Thompson JA; Contreras JL
    Surgery; 2003 Aug; 134(2):169-79. PubMed ID: 12947315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin.
    Chun KS; Kim SH; Song YS; Surh YJ
    Carcinogenesis; 2004 May; 25(5):713-22. PubMed ID: 14729583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. JunD attenuates phenylephrine-mediated cardiomyocyte hypertrophy by negatively regulating AP-1 transcriptional activity.
    Hilfiker-Kleiner D; Hilfiker A; Castellazzi M; Wollert KC; Trautwein C; Schunkert H; Drexler H
    Cardiovasc Res; 2006 Jul; 71(1):108-17. PubMed ID: 16690042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variations in Jun and Fos protein expression and AP-1 activity in cycling, resting and stimulated fibroblasts.
    Lallemand D; Spyrou G; Yaniv M; Pfarr CM
    Oncogene; 1997 Feb; 14(7):819-30. PubMed ID: 9047389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activator protein 1 DNA binding activity is decreased in lesional psoriatic skin compared with nonlesional psoriatic skin.
    Johansen C; Kragballe K; Rasmussen M; Dam TN; Iversen L
    Br J Dermatol; 2004 Sep; 151(3):600-7. PubMed ID: 15377346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.